We exist to solve a problem that shouldn't exist.

Breakthrough healthcare technologies fail to reach patients every day. Not because the science is wrong, but because they can't access the right capital at the right time. Meanwhile, institutional investors waste resources sorting through unqualified opportunities, missing genuine innovations buried in the noise.

Méridian Strategic Advisors bridges this gap.

We operate a curated marketplace connecting institutional capital with vetted life sciences opportunities. We're selective, rigorous, and completely aligned with the success of every company we represent.

How We Work - We serve two client groups:

Life Sciences companies retain us for comprehensive due diligence, strategic positioning, and introductions to our institutional investor network. We take on no more than five companies at a time, and when funding closes, we take half our success fee in equity. This structure ensures we're betting on companies we genuinely believe in.

Institutional investors—PE firms, VCs, and family offices—engage us on a membership basis for access to pre-vetted opportunities that match their specific investment criteria. No noise. No wasted time. Only companies that have passed rigorous screening for corporate structure, financial sustainability, IP ownership, management capability, and ethical standards.

Why This Model Works - Quality over volume benefits everyone.

Startups gain access to serious capital without wasting months on investors who won't close. Investors see only opportunities that genuinely merit their attention. And we maintain the relationships and reputation that make meaningful introductions possible.

We bring decades of experience across investment advisory, operational leadership, and entrepreneurship. But what drives this practice is a commitment to ensuring healthcare innovations reach the patients who need them.

Schedule a Meeting

Contact us at +1 949.629.4199 or info@meridianstrategicadvisors.com

Serious inquiries only. We work with companies that will make a difference.

Our Values

Uncompromising Standards

We don't move forward with opportunities that don't meet our criteria—regardless of their science or potential fees. This protects our clients on both sides and maintains the trust that makes meaningful introductions possible.

Complete Alignment

Taking equity in every success fee isn't just compensation—it's a statement. We're betting on the companies we represent with our own capital, not just our time. When you win, we win. When you don't, neither do we.

Rigorous Due Diligence

We conduct the same comprehensive assessment whether working for companies or investors. Corporate structure, financials, IP ownership, management capability, milestone achievement, and operational integrity. If it doesn't pass scrutiny, it doesn't move forward.

Absolute Discretion

Your business remains your business. Period. Confidentiality isn't a value we claim—it's fundamental to how we operate. Every conversation, every document, every introduction is handled with institutional-level discretion.

Quality Over Volume

Five clients maximum. This isn't marketing language—it's how we ensure every engagement receives the attention, rigor, and strategic thinking it deserves. We're selective because our clients demand excellence, not activity.

Direct Communication

We tell you what you need to hear, not what you want to hear. If there's a problem with your cap table, management team, or milestone timeline, you'll know immediately. Clarity serves long-term success better than comfort.

Decades of Experience

Investment advisory, operational leadership, and entrepreneurship across multiple sectors. We understand both capital allocation and business operations—not just one or the other.

Benoît Lapointe

Founder & CEO, Méridian Strategic Advisors

I perform comprehensive due diligence on biotech startups, assessing management integrity, intellectual property control, and financial sustainability, to identify credible opportunities and facilitate introductions to institutional capital partners. This select group of institutional investors and family offices are actively deploying capital into life sciences companies.

I am driven by a commitment to ensuring healthcare innovations reach the patients who need them.

How I Work

I serve two distinct client groups:

For Biotech Companies: I work with established life sciences startups on a consulting retainer basis. This engagement covers comprehensive due diligence, strategic positioning for investors, and introductions to my network of institutional capital sources. When funding closes through my introductions, I take half my success fee in equity. This structure ensures I'm genuinely invested in your long-term success, not just a quick transaction.

For Investors: Private equity firms, venture capital funds, and family offices engage me on a membership basis. They define their investment criteria—stage, therapeutic area, capital requirements, timeline—and I source opportunities that match. Instead of sorting through hundreds of unqualified pitches, they see only companies I've personally vetted and believe merit serious consideration.

My Approach

I take on no more than five companies at a time because both my startup clients and my investor clients expect quality over volume. This selectivity allows me to conduct the thorough due diligence that protects everyone's interests and maintains the trust that makes this model work.

My due diligence process examines corporate structure, financial sustainability, intellectual property ownership, management capability, milestone achievement, ethical standards, and operational integrity. Companies that don't meet these standards don't move forward, regardless of how compelling their science might be.

This rigor serves everyone. Startups gain access to serious capital without wasting months on investors who won't close. Investors see only opportunities that genuinely match their criteria. And I maintain the relationships that allow me to continue making quality introductions.

My Background

I bring decades of experience across investment advisory, operational leadership as a regional director for a manufacturing firm, and building businesses as an entrepreneur. This combination gives me perspective on both the financial and operational realities that determine whether a company will succeed.

But what truly drives this practice is a lifelong passion for healthcare innovation. I've watched too many breakthrough technologies fail to reach patients—not because the science was wrong, but because they couldn't access smart capital at the right moment. This work exists to solve that problem: ensuring worthy innovations get funded while protecting investors from ventures that aren't ready.

I came to life sciences from commercial real estate, where I learned that the best transactions happen when both parties trust the intermediary. That trust comes from rigorous standards, honest assessment, and genuine alignment of interests. It's the foundation of everything I do.

To discuss potential collaboration, contact my office to arrange a confidential meeting.

We exist to solve a problem that shouldn't exist.

Mission

Vision

Our Values

Founder & CEO | Life Sciences Capital Advisor

Benoît Lapointe